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Hair analysis is a reliable tool for detecting long-term exposure to illegal drugs, including amphetamine-
type stimulants, over periods from a few weeks to a few months, depending on the length of the hair used 
for analysis. Between 2000 and 2012, over 600 hair samples were analysed at the Institute for Medical 
Research and Occupational Health, Croatia (IMROH) for the presence of amphetamine-type stimulants. 
IMROH has used the same procedure for testing hair samples for amphetamine-type stimulants for over 
twelve years. It was found to be reliable for confirming repeated abuse of amphetamine-type stimulants. 
Gas chromatography/mass spectrometry (GC/MS) was used to determine amphetamine, methamphetamine, 
3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxymethamphetamine (MDMA-Ecstasy), and 
3,4-methylenedioxyethylamphetamine (MDEA) in hair. Hair samples were either taken at the Institute, 
delivered by mail or a third person brought them to the laboratory. In most cases, the hair samples were 
tested anonymously. A total of 23 % of the tested samples were positive for one or more amphetamine-type 
stimulant. MDMA was the most frequently detected substance, whereas the most frequent combination 
was amphetamine with MDMA. Our results could indicate a trend in amphetamine-type stimulant abuse 
among young people in the Republic of Croatia.
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Amphetamine-type stimulants usually refer to 
syn the t i c  subs t ances  l i ke  amphe tamine , 
m e t h a m p h e t a m i n e ,  3 , 4 - m e t h y l e n e d i o x y -
m e t h a m p h e t a m i n e  ( M D M A - E c s t a s y ) , 
3,4-methylenedioxyamphetamine (MDA), and 
3,4-methylenedioxyethylamphetamine (MDEA) that 
act as central nervous system stimulants. According 
to data provided by the European Monitoring Centre 
for Drugs and Drug Addiction (1), approximately one 
quarter of Europe’s adult population have used an 
illicit drug at some point in their lives and approximately 
3.8 % of all Europeans aged 15-64 have consumed 
amphetamines at least once in their lifetime (2). A 
study conducted by the Ivo Pilar Institute of Social 
Science on illicit drug use in the general Croatian 
population (4,756 respondents) showed that 16 % of 
adults aged 15-64 reported taking at least one type of 
drug of abuse in their lifetime (3). Amphetamine-type 
stimulants are the second most frequently used illicit 
drugs after cannabis: the lifetime prevalence of taking 
cannabis in Croatia is 15.6 %, followed by 
amphetamines (2.6 %) and ecstasy (2.5 %). The main 
concern is the higher lifetime prevalence (25.7 %) of 
taking an illegal drug among the 15-34 age group. In 
the same age group, the lifetime prevalence rate of 
taking amphetamine-type stimulants was two times 
higher than among all adults (aged 15-64). Around 
23 % of respondents who had taken an amphetamine-
type stimulant at least once reported their first 
experience with these illegal drugs at an age between 
16 and 17. The second main concern is that, after years 
of declines in the quantity of amphetamine-type 
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stimulants seized, a rise was recorded in 2011 (4). In 
a comprehensive study performed in a Zagreb 
wastewater treatment plant in 2009, a consumption of 
1–3 kg per year amphetamine-type stimulants was 
estimated based on their analysis in wastewater. The 
authors concluded that the amphetamine-type drug 
consumption rate in the city of Zagreb (3.6–9.7 mg 
per day in 1000 inhabitants) is comparable to that in 
Italy and Switzerland, but significantly lower than in 
UK and Spain (5).
Due to the abovementioned reasons, the early 
identification of drug abuse in the general population 
is critical in planning preventative action and reducing 
the damage caused by illicit drug use. Unlike urine, 
in which the generally accepted detection time for 
amphetamine-type stimulants is 1 to 3 days, hair 
provides information on long-term exposure to 
amphetamine-type stimulants over a period from a 
few weeks to a few months, depending on the length 
of the hair collected (6). 
Since 2000, the Institute for Medical Research and 
Occupational Health in Zagreb, Croatia (IMROH) has 
provided quantitative hair analyses for amphetamine-
type stimulants for a wide variety of customers 
including private customers, addiction prevention 
centres, hospitals, courts, and employers. The aim of 
this paper is to provide an overview of amphetamine-
type stimulant abuse in Croatia, as well as to evaluate 
the different characteristics of the hair samples 
analysed at the Institute with regard to how and from 
whom they were received.
MATERIALS AND METHODS
Hair samples 
Hair samples (n=666) from various sources were 
received or taken in the laboratory. A strand of hair of 
approximately 5 mm in diameter was cut from close 
to the scalp at the vertex posterior area, folded in 
aluminium foil or paper, and the proximal and distal 
ends were marked. We analysed hair segments 2-4 cm 
long from the proximal end, which represent 
approximately 2-4 months of hair growth as stated in 
the literature (7). The study was conducted according 
to the ethical standards of the Helsinki Declaration 
and was approved by the IMROH Ethics Committee. 
The investigation presented in this paper was 
performed within a wider research project entitled 
”Identification of drug abuse by comparative analysis 
of biological specimens” and funded by the Ministry 
of Science and Technology of the Republic of Croatia.
Hair analysis
Hair samples were analysed according to a 
previously validated procedure (8). The gas 
chromatography/mass spectrometry (GC/MS) method 
was developed for determining amphetamine, 
methamphetamine, MDMA, MDA, and MDEA in 
hair. Over the years, a few procedural modifications 
were done (reagent and standard suppliers were 
changed and deuterated internal standards were 
purchased). All of the changes were fully validated 
before routine laboratory work. In brief, the hair was 
washed in dichloromethane, dried, cut into very small 
pieces, and 50 mg of hair was used for analysis. Hair 
samples were submitted to alkaline digestion with 
1 mol L-1 sodium hydroxide at 70 °C for 20 min prior 
to extraction with ethyl acetate (2x1 mL). The extract 
was evaporated to dryness in the presence of a 100 μL 
mixture of methanol:hydrochloric acid (99:1, v/v) to 
prevent a loss of volatile amphetamine and derivatizated 
with 50 μL of heptafluorobutyric anhydride (HFBA) 
at 60 °C for 30 min. The derivatizated samples were 
evaporated to dryness, and reconstituted in 100 μL of 
ethyl acetate for injection of 1 μL onto a gas 
chromatograph Varian 3400 CX with Saturn ion trap 
mass spectrometer equipped with HP-5MS capillary 
column (5 % diphenyl-95 % dimethylpolysiloxane, 
30 m, 0.25 mm ID, 0.25 μm film  thickness; J&W 
Agilent Technologies; Santa Clara, USA). Three ions 
for the analytes and two ions for the internal standards 
were monitored in the selected ion monitoring (SIM) 
mode. The following ions were used for each drug: 
amphe t ami ne -HFBA ,  m / z  240 ,  118 ,  91 ; 
methamphetamine-HFBA, m/z 254, 210, 118; MDA-
HFBA, m/z 135, 162, 240; MDMA-HFBA, m/z 162, 
254, 210; MDEA-HFBA, m/z 268, 135, 162; 
amphetamine-d5-HFBA, m/z 244, 92; and MDMA-d5-
HFBA, m/z 258, 165. The underlined ions were used 
for quantitation.The standards were prepared in blank 
hair extracts. Each case sample batch included 
standards and positive and negative control. The 
precision expressed as relative standard deviation 
(RSD) was <9 % and the accuracy was >85 % for all 
of the 5 analytes. The limit of detection ranged from 
0.01 ng mg-1 to 0.05 ng mg-1. The confirmation cut-off 
for amphetamine-type stimulants was 0.2 ng mg-1. 
External quality assessment was performed through 
participation in the Proficiency Testing programme 
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organised by the Society of Hair Testing (9). For the 
purpose of this study, all data above the limit of 
detection were included.
RESULTS AND DISCUSSION
During the period from 28 April 2000 to 10 
December 2012, 666 hair samples were analysed. A 
large majority of our customers were parents who had 
suspected their children of taking drugs – primarily 
amphetamine-type stimulants. In most instances, a 
third person (e.g., parent) brought the hair sample for 
analysis (40 %). In other cases, hair samples were 
taken at IMROH by trained personnel (37 %) or 
delivered by mail (23 %). In 73 % of cases, hair 
samples were tested anonymously (e.g., the hair 
samples were received under only the first or a 
fictitious name, or a number). Hair analysis requests 
from private customers accounted for approximately 
92 % of the total number of samples. Less than 8 % 
of cases included hair samples tested for official 
purposes [addiction prevention centres and hospital 
requests (3.8 %), workplace drug testing (2.7 %), and 
court proceedings (1.4 %)]. The probable reason for 
such a low percentage of official requests in Croatia 
compared to e.g. United Kingdom (10) is that hair 
testing for illegal drugs has not yet been included in 
any Croatian law or regulation.
The main drawbacks in case of sampling hair from 
a third person are the lack of control regarding 
protocols and the ability to collect hair ”next to the 
scalp”. LeBeau et al. (11) suggested that, beside the 
variability in the growth rate, inconsistent collection 
may have an important impact on the interpretation 
of results.
Among customers who could be identified by 
gender (they came personally to the laboratory) males 
were more likely to be positive (23 % of positive males 
vs. 17 % of positive females), which is in accordance 
with studies by Strote at al. (12), Martins et al. (13), 
and Molinaro et al. (14), who reported a higher 
prevalence of illegal drug use among males. Also, 
males were 2.5 times more frequent clients compared 
to females.
Table 1 summarises the positive results of hair 
testing (n=155), in which one or more type of drug 
were found. A total of 23 % of the tested samples were 
positive for one or more amphetamine-type stimulant. 
Among the hair samples received, 25 % of samples 
from users who provided their identity tested positive 
compared to 20 % of positive hair samples received 
anonymously. Considering single drug use, MDMA 
was the most frequent detected substance (in 10 % of 
the samples), followed by amphetamine (5 %). The 
most frequent combination was amphetamine with 
MDMA (5 % of all hair samples). Methamphetamine 
was detected in only 1 % of hair samples. In less than 
2 % of hair samples, we detected methamphetamine 
+ MDMA, amphetamine + methamphetamine, 
amphetamine + methamphetamine + MDMA or 
amphetamine + MDMA + MDA + MDEA.
According to surveys conducted on a large sample 
size in Norway (15), Australia (16), United States (13), 
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Table 1 Distribution of positive hair samples (n=155) based on the presence of certain amphetamine-type stimulants and their 
combinations in the 2000-2012 period









anot detected in all samples; MDMA - 3,4-methylenedioxymethamphetamine; 
MDA - 3,4-methylenedioxyamphetamine; MDEA - 3,4-methylenedioxyethylamphetamine
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and Taiwan (17), MDMA appeared to be the most 
commonly used illegal drug in adolescents and young 
adults. The prevalence of MDMA in our study was 
not surprising since most of our clients were 
adolescents and young adults considered to be frequent 
consumers of MDMA. In addition, MDMA is easily 
available and relatively cheap. Growing concerns have 
been raised about ecstasy use during adolescence 
because young ecstasy users tend to be more naive 
and more vulnerable to the harmful effects. The small 
number of samples positive for methamphetamine 
could be explained by its low accessibility and 
relatively high price (4). The levels detected for 
amphetamine-type stimulants are presented in Table 2.
The measured concentrations were in accordance 
with already published concentration ranges (10, 18, 
19). Among the 109 cases positive for MDMA, its 
metabolite MDA was detected in 23 cases. The MDA/
MDMA ratio in hair ranged from 0.01 to 0.25, which 
was in agreement with earlier observations (20). In 
most of the MDMA positive samples (73.4 %), MDMA 
was found in mass fractions up to 5.0 ng mg-1, which 
is in accordance with previously reported results (21). 
Amphetamine was found in 77 cases, 36 of which 
exhibited a co-occurrence with MDMA, which is 
generally the most frequent combination. The probable 
reasons for the wide range of mass fractions for 
amphetamine and MDMA could be the different 
purity, frequency, and amount consumed. Also, the 
different hair treatments in 10 % of the analysed hair 
samples could be the reason for a slight decrease of 
drug content in those hair samples, which has been 
documented by several authors (18, 22, 23).
Interpretation of hair analysis results is a very 
challenging process due to several possible sources 
of error. In addition to different hair growth rate and 
errors in sampling, a possible problem in hair analysis 
could be false positive hair testing result caused by 
passive exposure to drug from the environment. 
Therefore, a decontamination step using appropriate 
solvents is necessary prior to the analysis of hair 
samples (24). In addition, another problem is the lack 
of correlation between frequency of drug use and its 
concentration in hair due to the different incorporation 
rate of drug in the hair, different hair melanin content, 
use of hair treatments (bleaching and dyeing), etc. 
Pharmacogenetic variations also play an important 
role in the interpretation of hair analysis results (25).
CONCLUSIONS
It is evident that hair is a reliable biological marker 
for cumulative exposure to illicit drugs. IMROH has 
used the same hair sample testing procedure for 
amphetamine-type stimulants for over twelve years. 
This method was found to be reliable for confirming 
repeated amphetamine-type stimulant abuse. Our 
study can serve to provide a preliminary idea about 
the trend of amphetamine-type stimulant abuse among 
adolescents and young adults in Croatia.
Acknowledgements
Author’s attendance of the TIAFT2013 Congress 
(where this study was presented) was supported by a 
donation from Biovit, Croatia. The authors also wish 
to thank Ms Vesna Triva for her most skilful technical 
assistance.
Brčić Karačonji I and Brajenović N. DETECTION OF AMPHETAMINES THROUGH HAIR ANALYSIS
Arh Hig Rada Toksikol 2014;65:225-230
Table 2 Mass fraction of certain analytes determined in hair samples
Analyte Number of positive samples Mass fraction (ng mg
-1) 
median (range)
MDMA 109 2.30 (0.45-90.8)
Amphetamine 77 1.51 (0.15-118.7)
MDA 23 0.81 (0.18-4.64)
Methamphetamine 20 0.67 (0.10-2.01)
MDEA 1 2.13 (-)
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Sažetak
Evaluacija zlouporabe stimulansa amfetaminskog tipa putem analize kose: rezultati 
dvanaestogodišnjeg rada
Analiza kose pouzdan je način za detektiranje dugotrajnog konzumiranja ilegalnih droga, uključujući 
stimulanse amfetaminskog tipa u razdoblju od nekoliko tjedana do nekoliko mjeseci, ovisno o duljini kose 
koja se koristi za analizu. Od 2000. do 2012. u Institutu za medicinska istraživanja i medicinu rada 
analizirano je više od 600 uzoraka kose na prisutnost stimulansa amfetaminskog tipa. Vezani sustav plinski 
kromatograf/spektrometar masa koristio se za određivanje masenog udjela amfetamina, metamfetamina, 
3,4-metilenedioksiamfetamina (MDA), 3,4-metilenedioksimetamfetamina (MDMA-Ekstazi) i 
3,4-metilenedioksietilamfetamina (MDEA) u kosi. Uzorci kose  uzimani su u Institutu, dostavljeni su 
poštom ili ih je treća osoba donijela u laboratorij. U većini slučajeva uzorkovanje i analiza kose obavljeni 
su anonimno. Dvadeset tri posto analiziranih uzoraka kose bilo je pozitivno na jedan ili više stimulansa 
amfetaminskog tipa. Najčešće je detektiran MDMA, a najčešća kombinacija stimulansa bila je amfetamin 
s MDMA. U Institutu se postupak za testiranje uzoraka kose na prisutnost stimulansa amfetaminskog tipa 
provodi više od 12 godina i smatra se pouzdanim načinom potvrde ponavljanog konzumiranja tih stimulansa. 
Naši rezultati mogu upućivati na trend zloporabe stimulansa amfetaminskog tipa među mlađom hrvatskom 
populacijom.
KLJUČNE RIJEČI: GC/MS; kvantitativno određivanje; MDMA; metamfetamin
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